Cadence Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-19,347
| Closed | -$544K | – | 628 |
|
|
2016
Q2 | $544K | Sell |
19,347
-6,734
| -26% | -$189K | 0.04% | 431 |
|
|
2016
Q1 | $948K | Buy |
26,081
+390
| +2% | +$14.2K | 0.07% | 308 |
|
|
2015
Q4 | $1.03M | Sell |
25,691
-11,907
| -32% | -$476K | 0.07% | 278 |
|
|
2015
Q3 | $1.07M | Sell |
37,598
-11,072
| -23% | -$315K | 0.08% | 280 |
|
|
2015
Q2 | $1.6M | Buy |
48,670
+10,500
| +28% | +$346K | 0.09% | 282 |
|
|
2015
Q1 | $1.1M | Buy |
38,170
+360
| +1% | +$10.4K | 0.07% | 389 |
|
|
2014
Q4 | $1.03M | Sell |
37,810
-38,577
| -51% | -$1.05M | 0.06% | 395 |
|
|
2014
Q3 | $1.63M | Sell |
76,387
-106,980
| -58% | -$2.28M | 0.09% | 281 |
|
|
2014
Q2 | $4.12M | Buy |
+183,367
| New | +$4.12M | 0.2% | 201 |
|